Proteomics

Dataset Information

0

Role of BTG1 inactivation in lymphomagenesis and lymphoma dissemination

ABSTRACT: BTG1 is recurrently mutated in the MCD/C5 subgroup of diffuse large B cell lymphoma (DLBCL), but the functions of this gene in lymphomagenesis have never been investigated so far. Here we provide evidence that Btg1 knock out accelerates the development of a lethal lymphoproliferative disease driven by Bcl2 overexpression. Exploring the clinical association between BTG1 mutation and extranodal dissemination, we discovered BCAR1 as a new BTG1 partner. Following BTG1 inactivation, overactivation of the BCAR1-RAC1 pathway induced major remodeling of the actin cytoskeleton and increased migration capacities of lymphoma cells in vitro and in vivo. These modifications were targetable with the SRC inhibitor dasatinib, which opens interesting clinical perspectives in BTG1 mutated DLBCL

INSTRUMENT(S): Q Exactive HF

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Laurent GENESTIER  

PROVIDER: MSV000089045 | MassIVE | Thu Mar 10 23:59:00 GMT 2022

REPOSITORIES: MassIVE

Json Xml
altmetric image

Publications

Understanding the functional role of mutated genes in cancer is required to translate the findings of cancer genomics into therapeutic improvement. BTG1 is recurrently mutated in the MCD/C5 subtype of diffuse large B-cell lymphoma (DLBCL), which is associated with extranodal dissemination. Here, we provide evidence that Btg1 knock out accelerates the development of a lethal lymphoproliferative disease driven by Bcl2 overexpression. Furthermore, we show that the scaffolding protein BCAR1 is a BTG  ...[more]

Similar Datasets

Transcriptomics Expression Data from Burkitt Lymphoma Patients
2006-07-04 | E-GEOD-4732 | biostudies-arrayexpress
Transcriptomics Expression of TCF3 target genes defines a subclass of diffuse large B-cell lymphoma characterized by up-regulation of MYC target genes and poor clinical outcome following R-CHOP therapy
2022-11-10 | GSE212114 | GEO
Transcriptomics Transcription profiling of follicular lymphoma to diffuse large cell lymphoma
2005-09-23 | E-SMDB-963 | biostudies-arrayexpress
Other Gene expression analysis in canine diffuse large B cell lymphoma (DLBCL)
2023-08-29 | GSE213088 | GEO
Genomics Affymetrix SNP array data for follicular lymphoma (FL) and transformed follicular lymphoma (tFL) samples
2013-10-01 | GSE42525 | GEO
Transcriptomics Frequent mutations of FBXO11 identify BCL6 as a therapeutic target in Burkitt Lymphoma
2021-12-31 | GSE159303 | GEO
Transcriptomics A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
2006-06-07 | GSE4475 | GEO
Transcriptomics Gene and microRNA expression data of diffuse large B cell lymphoma from human diagnostic frozen samples
2011-08-01 | E-GEOD-21849 | biostudies-arrayexpress
Transcriptomics The genetic landscape of mutations in Burkitt lymphoma
2013-07-01 | GSE48435 | GEO
Transcriptomics caArray_golub-00095: Diffuse large B-cell lymphoma outcome prediction
2015-05-15 | E-GEOD-68895 | biostudies-arrayexpress